CClinicalTrials.gg
RecruitingNCT07330427Updated Jan 9, 2026

Impact of Health Education on Knowledge, Attitude and Practice of Post-exposure Prophylaxis

An interventional study of Health Education in Post Exposure Prophylaxis, sponsored by Aswan University. Recruiting at 1 site in Egypt. Open to participants aged 19 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-09.

Sponsored by Aswan University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Feb 2026, 8 months ago, but the record still lists the study as recruiting.
  • Registered 6 months after the study started (first participant enrolled Jun 2025, registered Dec 2025).
  • Started Jun 2025; still recruiting 1 year 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
340
Allocation
Not applicable
Ages
19 Years to 55 Years
Sex
All
01

Study summary

Occupational exposure to blood-borne pathogens, such as human immune-deficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) for healthcare workers through contact with human blood and body fluids has become a major health concern as it poses a risk of transmission of these infectious agents.

According to the World Health Organization (WHO) report, about three million HCWs are exposed to blood-borne pathogens each year, of which 170,000 are exposed to HIV infections, 2 million to HBV infections, and 0.9 million to HCV infections. Most of the time, healthcare providers get exposure through the splash of blood or other body fluids into the eyes, nose, or mouth or nonintact skin exposure, and percutaneous injury occurs as a result of a break in the skin caused by a needlestick or sharps contaminated with blood or body fluids

Read the detailed description

Post exposure prophylaxis is defined by the World Health Organization (WHO) as the medical intervention offered to prevent the transmission of blood-borne diseases following a potential exposure to HIV, HBV, HCV, and other viruses.

In developing regions, 40%-65% of HBV and HCV infections in health care workers are attributable to percutaneous occupational exposure .Approximately 3 out of 35 million HCWs worldwide experience needlestick injuries (NSIs) annually, exposing them to blood-borne pathogens .

In Egypt, like many developing countries, few efforts have been undertaken to raise awareness about needlestick injury (NSI) among HCWs . There is a lack of regulations and policies to protect HCWs from exposure. HCWs rarely receive training in infection control and standard precautions, even though these are low-cost solutions to reducing the risk of sharp injuries and have a high likelihood of being adopted .

There is a lack of data and surveillance concerning health care-related occupational exposures and the use of PEP. Furthermore, unsafe practices are frequently observed, placing patients and healthcare workers at risk of infection.

knowledge and practice of PEP for HIV/HBV. As a result, the study recommended the establishment of PEP training centre with proper guidelines in order to enhance the utilization of PEP.

No empirical data exists on the knowledge and attitudes of HCWs toward post exposure prophylaxis following occupational exposure to the blood-borne viruses at Aswan University Hospital. Hence the study will apply interventions in the form of an education module designed to suit the need of each of these categories of HCWs (doctors, nurses, and ward aides). Furthermore, the study seeks to implement and evaluate the effectiveness of an education program regarding post exposure prophylaxis on their change in knowledge, attitude, and practice.

02

Conditions studied

  • Post Exposure Prophylaxis
03

In context

Lead sponsor

Aswan University is the lead sponsor of 47 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. HCWs at the selected departments (physicians, nurses and housekeepers).
  2. Age >18 years old and below 60 years old in both Genders.
  3. HCWs which have direct contact with blood and body fluids.

Exclusion criteria

Exclusion Criteria:

  1. Age\<18 years old and above 60 years old.
  2. Non-medical staff at Aswan university hospital.
  3. Health care workers which have no contact with blood or body fluids.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
340 participants (estimated)

Study arms

  • Experimental
    Health Care workers

    About 340 participants of heath care workers undergoing assessment of knowledge, attitude and practice about post-exposure prophylaxis among health care workers at Aswan university hospital, Egypt Then they will undergo lecturers about about post-exposure prophylaxis, then reassessment will be done after 3 months

    Procedure: Health Education

Interventions

  • ProcedureHealth Education

    1. Assess the baseline knowledge, attitudes and practices of health care workers at Aswan university hospital towards postexposure prophylaxis against blood-borne viral infection. 2. Provide an intense post exposure prophylaxis health education sessions. 3. Evaluate changes in post exposure prophylaxis knowledge, attitudes and practices after the health education intervention.

06

What researchers measure

Primary outcomes

  1. Health Practice Change

    Assessment of participants after taking health education lecturers about post-exposure prophylaxis regrading to knowledge, attitude and practice and this done by questionnaire as :The questionnaire consisted of three sections assessing knowledge, attitude, and practice regarding post-exposure prophylaxis (PEP). Section B assessed knowledge using nine close-ended questions, with adequate knowledge defined as ≥75% correct answers. Section C included seven items evaluating attitudes toward the importance and effectiveness of PEP, with scores ≥75% indicating a good attitude. Section D assessed PEP practices through nine questions, and good practice was defined as positive responses to more than 75% of items.

    Time frame: 3 Months

07

Study locations

1 of 1 sites recruiting
  • Aswan faculty of Medicine
    Aswān, Egypt
    • Shimaa Abdalaleem Abdalgeleel, Professor · Contact · +201092811522
    • Mohamed Mostafa Amin Ali, Professor · Contact · mohamed.mostafa@aswu.edu.eg · +201092811522
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07330427
Lead sponsor
Aswan University
Responsible party
Fatma Ali Mahmoud Hussein (Demonstrator at Public Health and Community Medicine, Faculty of medicine, Aswan University) — Principal investigator
First posted
Jan 9, 2026
Start date
Jun 1, 2025
Primary completion
Feb 1, 2026 (estimated)
Completion
Feb 1, 2026 (estimated)
Last update
Jan 9, 2026

Study contacts

Fatma Ali Mahmoud Hussein, MSc
Contact
fatma.mahmoud@med.aswu.edu.eg
+201153368599
Shaimaa Sayed Abdelrheem, Professor
Contact
dr_shimaasayed@yahoo.com
+201064031040
Shaimaa Sayed Abdelrheem, M.D
study chair · Associate Professor of Public Health and Community Medicine, Faculty of medicine, Aswan University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion